Speculation
Most of the alphal-antitrypsin in amniotic fluid is derived from the mother. It therefore appears that the only possible way of making a prenatal diagnosis of alphal-antitrypsin deficiency is by examination of blood from the fetus. One fetus examined in the present study had an abnormal Z-pattern. This abnormality may indicate a disturbance of fetal liver function already in utero.
The examination were done after informed consent from the women and the approval of the Ethical Committee at Lund, University Hospital.
Controls. Samples of maternal blood and amniotic fluid were collected from five women admitted for therapeutic abortion in the 16th to 20th wk of gestation. After the pregnancy had been terminated by hysterotomy. fetal blood was sampled by free flow from the pendant umbilical cord.
FETAL BLOOD SAMPLING
In case I, ultrasound scanning showed that the placenta covered the entire anterior wall of the uterus. Insertion of the fetoscope (Dyonics "Needlescope," 170 mm) through the abdominal flank lateral to the placental margin failed to reach the amniotic cavity. Later, the uterus was found to have rotated slightly around its longitudinal axis. and the fetoscope was now successfully inserted. Placental vessels were punctured without any attempt to cannulate, and samples of the stream of blood that issued into the amniotic fluid were aspirated (2) . In case 2, pure fetal blood was obtained by cannulation of a large vessel near the insertion of the umbilical cord into the placenta ( 18). In each woman, a sample of maternal blood was obtained from a cubital vein, and immediately before fetoscopy. a sample of amniotic fluid was obtained by fineneedle amniocentesis. The blood samvles were immediately transferred to EDTA tubes. Most of the alphal-antitrypsin (ulAT) in amniotic fluid is derived from the mother ( I , 7) and is therefore inappropriate for IDENTIFICATION OF FETAL BLOOD prenatal diagnosis of alAT deficiency. The only possibility of making such a diagnosis seems to be the examination of blood
The proportion of fetal and maternal red blood cells was from the fetus.
estimated by the Kleihauer technique (8) . In addition, the relation The development of techniques to obtain fetal blood in utero between HbA and HbF was assessed by electrofocusing at pH 3 has made prenatal diagnosis possible in fetuses at risk for alAT to 10 (4) . deficiency. We here report the prenatal evaluation of two fetuses at risk for alAT deficiency Pi ZZ.
EVALUATION OF THE DILUTION FACTOR
A preliminary report oh case I has been published previously (5).
The ratio of fetal blood to amniotic fluid in the fetoscopic samples was calculated from the hematocrit, assuming that the mean hematocrit in pure fetal blood at midpregnancy is 37% (3, MATERIALS A N D METHODS IS). In case I, the concentration of antichymotrypsin in fetal blood and amniotic fluid was also used in the calculation.
CLINICAL. MATERIAL
Case I. A Pi MZ father and a Pi MZ mother had two healthy PROTEIN QUANTITAT~ON children and one Pi ZZ girl who had died of cirrhosis of the livir The ofcr,AT was by e~ectro~mmunoas-at the age of 3 years. In the 22nd wk of a subsequent pregnancy, say ( I I ), a mixture of fetal blood and amniotic fluid was obtained at fetoscopy for prenatal diagnosis.
Case 2. A Pi M Z father and a Pi MZ mother had a Pi ZZ eirl.
ELECTROFOCUSING TECHNIQUE ' ,
The girl developed severe cirrhosis of the liver. At the age of 7
The fetoscopic samples were reduced with cysteine to a final years, an unsuccessful attempt to construct a portacaval shunt was concentration of 30 pmoles/ml to achieve a clear microheterogedone. In the 20th wk of a subsequent pregnancy, pure fetal blood neous pattern and less background staining. The freshly prepared was sampled at fetoscopy.
cysteine solution used consisted of 0.3 mM cysteine-HCI, 2 M 254 glycine, and 0.01 M EDTA with pH adjusted to 7.4 with NaOH. A volume of 10 p1 of the cysteine solution was mixed with 90 pI of plasma or serum and stored overnight at 4OC. Ready-prepared, thin-layer poly~crylamide gel plates with Am~h o l i n e at DH 4 to 5 ILKB. Bromma. Sweden) were used with 'LKB 21 17 'Multiphore'apparatus cooled at 1 5 "~ by an external cryostat (16) . Electrode strips were moistened with 1.0 M glycine at the cathodal end 1.0 M phosphoric acid at the anodal end. The gel was prerun at I hr with an LKB 2103 power supply at 500 V, 50 mA, and 20 W maximum. Samples of I5 p1 cysteine-reduced plasma were applied to filter papers ( 10 x 15 mm) on the gel. They were placed along the cathodal edge of the gel about 10 mm from the cathodal strip with about I mm between the papers to avoid mixing of the samples. For the analysis, the powe; supply was set at 1400 V. 50 mA, 20 W for 1 hr. and thereafter increased to 30 W for another 2 hr. Total effective running time, including prerun, was 4 hr.
After completion of electrofocusing. the gel was placed in fixative consisting of trichloroacetic acid (10%) and sulfosalicylic acid (5% w/v) for 30 to 60 min. Staining was performed in 0.4%) (w/v) of Coomassie R 250 and the destaining in a solution of methanol. acetic acid. and distilled water (35:10:55. v/v) for 45 min. The microheterogeneous pattern of u l AT was clearly visible after another 60 min in the destaining solution.
Reduced samples were diluted with 0.05 M glycine to a final alAT concentration of approximately 0.08 g/liter assuming that the mean alAT concentration in a normal population is 1.35 g/ liter (6).
Fifteen p1 of the dilution was subjected to electrofocusing as earlier described. Immunofixation was carried out on the surface of the electrofocusing gel after completion of the run using the "immunoprint technique" (17) . A cellulose acetate membrane (~e p r a p h d r e 111, Gelman) was soaked in alAT antiserum (IgGfraction. DAKO. Denmark) diluted with a 0.1 M ~h o s~h a t e buffer , , pH 7.4 (1:4). After completion of the run, the antibody-impregnated cellulose acetate membrane was placed over the expected trlAT area on the polyacrylamide gel for 1 hr. The membrane was soaked in phosphate buffer overnight, stained for 5 min in 0.2% Coomassie R 250. and destained in the methanol, acetic acid, and water mixture. 
RESULTS

Samples
DIAGNOSTIC CASES
On examination by the Kleihauer technique. all the fetoscopic samples were found to contain >95% fetal red blood cells. Electrofocusing run on hemolysates from isolated red cells showed that the proportions between the two HbF and the minor HbA fractions were typical in all the samples. indicating fetal origin.
CASE I
In all samples obtained from case I. the fetal blood was diluted with amniotic fluid. In the sample with the highest hematocrit, that is the least diluted sample, it was 15%. In this sample, the concentration of alAT was 0.38 g/liter; in pure amniotic fluid, 0.24 g/liter. Calculated from the hematocrit. the ratio of fetal blood to amniotic fluid was about 2:3 in the fetoscopic sample. The antichymotrypsin concentration in amniotic fluid is higher than in fetal blood. The mixture will thus have a lower concentration than pure amniotic fluid depending on the dilution with fetal blood. The ratio of the mean ulAT to antichymotrypsin concentration in the controls was 12:l. When the concentrations in amniotic fluid, 0.1 10 g/liter, and in the mixture, 0.076 g/liter, were compared with the corresponding al-AT values, a similar ratio of approximately 2:3 was obtained. From this ratio, the fetal plasma concentration of alAT was calculated as 0.6 g/liter. This value is consistent with a fetal contribution of alAT. at least from a Pi M Z subject. Assuming the same relation between the a]-AT concentration and the Pi-type in a fetus as in a newborn, a Pi ZZ fetus would have about 10% of the normal fetal plasma alAT concentration, that is, about 0.1 g/liter, and a Pi M Z fetus would have 70%, that is, about 0.5 g/liter (12) . The electrofocusing of this sample showed that the density of the major Pi M bands was greater than that in pure amniotic fluid. suggesting a fetal contribution of M protein. The identity of the a I A T fractions was further demonstrated by immunofixation (Fig. I) . Thus. the alAT concentration and the electrofocusing pattern showed that the fetus had at least one PiM gene and, accordingly, did not have aIAT deficiency.
The pregnancy was uncomplicated and a healthy girl was born in the 41st wk of gestation. Analysis of plasma from the newborn infant showed a heterozygous Pi M Z pattern. and the concentration of a l A T was 0.95 g/liter.
CASE 2
The sample obtained in case 2 was collected by cannulation of a large vessel near the insertion of the cord. The hematocrit was 39%. The a , A T concentration in the fetal plasma was 0.06 g/liter, in amniotic fluid, the alAT concentration was 0.15 g/liter. The fetal plasma had a Pi ZZ pattern both at electrofocusing and immunofixation (Fig. 2) . However, the pattern was not normal: thus a doubling of the major bands was observed even after reduction. The Pi MZ pattern of amniotic fluid was identical with that of case I . The findings indicated an alAT-deficient fetus. The pregnancy was terminated, and examination of blood from the abortus confirmed the diagnosis of severe a l A T deficiency.
The examination of the liver from the abortus showed sings of cholestasis. No inclusion bodies were visible in the hepatocytes. mother. Arrou~s, norn~al 2 , and Z,; fractions. h, the corresponding immunofixation pattern indicating that the abnormal fractions (dots) represent tr,AT.
JEPPSSON ET AL.
DISCUSSION
Recently. Roth et al. (19) used only amniotic fluid proteins to determine the phenotype of a fetus at risk for alAT deficiency. However, it has been shown that amniotic fluid proteins are mainly of maternal origin (1. 7). Our results clearly show that the fetal alAT phenotype is fully expressed in fetal plasma in midpregnancy and that the amniotic fluid protein cannot be used for prenatal diagnosis of a I A T deficiency.
We have thus shown that the phenotype and the concentration of alAT can be determined in a fetoscopic sample of fetal blood even when diluted with amniotic fluid. However, pure fetal blood is preferable, as shown in case 2. lmmunofixation of good quality is a prerequisite because the actual area on the electrofocusing pattern can sometimes be covered by other smearing proteins, which render interpretation more difficult. Also heparin, when used as an anticoagulant instead of EDTA, can have the same effect on the pattern. Why the Z-allele contribution was weaker in the MZ amniotic fluid is unknown.
In case 2, the Z-pattern was abnormal (Fig. 2) . suggesting a disturbed alAT-production by the liver. This disturbance may be due to the liver disease confirmed by the cholestasis observed at autopsy. However, in another study we found no abnormalities in the Pi patterns of 60 Pi ZZ infants including seven with neonatal cholestasis studied at about 3 months of age (Jeppsson and Sveger, unpublished results). Inasmuch as to our knowledge case 2 is the first fetus with a]-AT deficiency and cholestasis studied in utero. the significance of the abnormal PiZ pattern is unknown.
The liver and the yolk sac produce (YIAT, but the contribution from the yolk sac is no longer detectable after the l lth wk of gestation (I). At about 10 wk, the a I A T concentration is 70% of the adult level, which is reached at 26 wk (I). At term, the mean serum level is 150% in the fetus compared with 200% in the mother (10) . A maternofetal transfer of aIAT has. to our knowledge, not been measured directly. However, judging from comparison of genetic types of transferrin ( 13) . Gc-globulin (7) . orosomucoid (7) , and albumin in amniotic fluid and maternal serum, most amniotic fluid proteins are of maternal origin. Our findings showed the same for alAT. With the methods used, however, it was not possible to detect a 5 to 10% contribution from the fetus to the amniotic fluid proteins.
In Scandinavia. I out of 1500 individuals has alAT deficiency Pi ZZ (9) . In a prospective study of 120 Swedish Pi ZZ infants, 11% developed neonatal cholestasis. and another 7% had other clinical symptoms of liver disease one out of every two infants with neonatal cholestasis was small for gestational age, which may indicate that the infant had the disease already in utero (20) . It has been estimated that the risk for two Pi MZ parents to have a child with alAT deficiency Pi ZZ and congenital liver disease progressing to cirrhosis is 1 to 2% (14, 20) .
Thus, prenatal examination for alAT deficiency may be considered in fetuses of women who have already borne a Pi ZZ child with sever liver disease and who request prenatal diagnosis in a subsequent pregnancy.
